Financial Performance - The company's operating revenue for the third quarter of 2021 was ¥904,360,412.16, an increase of 4.74% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥12,961,008.30, a decrease of 42.07% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,581,130.50, down 55.35% from the previous year[5]. - The basic earnings per share for the period was ¥0.0388, reflecting a decline of 42.09% compared to the same period last year[5]. - Net profit for the first nine months was RMB 59,175,133.78, a decrease of 19.0% from RMB 73,014,248.13 in the previous year[25]. - Operating profit for the first nine months was RMB 75,162,288.25, down 18.6% from RMB 92,290,604.67 year-on-year[25]. - The company’s investment income was RMB 5,879,727.40, down from RMB 7,475,433.57 in the same period last year[25]. Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥2,798,597,112.81, representing a 3.60% increase from the end of the previous year[5]. - Total assets increased by 54,579,301.97 RMB, reaching 2,755,858,351.15 RMB[19]. - Total liabilities amounted to RMB 968,397,586.93, an increase from RMB 939,286,554.16 in the previous year, reflecting a growth of approximately 3.8%[24]. - Non-current liabilities totaled RMB 156,061,924.37, an increase from RMB 108,407,333.28, indicating a growth of approximately 44.0%[24]. - The total equity attributable to shareholders of the parent company was RMB 1,812,936,960.12, compared to RMB 1,741,455,077.20, representing a growth of approximately 4.1%[21]. Cash Flow - The net cash flow from operating activities was negative at -¥27,427,802.90, a decline of 153.49% compared to the previous year[5]. - Operating cash inflow for the first nine months of 2021 was RMB 2,691,524,934.42, an increase of 6.54% compared to RMB 2,526,158,645.67 in the same period last year[26]. - Operating cash outflow for the same period was RMB 2,718,952,737.32, up from RMB 2,474,886,165.18, resulting in a net cash flow from operating activities of RMB -27,427,802.90[26]. - Investment cash inflow decreased to RMB 417,612,400.60 from RMB 676,825,322.47, while investment cash outflow was RMB 573,142,233.78, leading to a net cash flow from investing activities of RMB -155,529,833.18[26]. - Financing cash inflow was RMB 50,000,000.00, while financing cash outflow totaled RMB 97,358,409.41, resulting in a net cash flow from financing activities of RMB -97,358,409.41[26]. - The company experienced a net decrease in cash and cash equivalents of RMB 280,333,693.88 during the reporting period[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 25,103[11]. - The largest shareholder, Shaoxing Zhenyuan Health Industry Group Co., Ltd., holds 24.93% of shares, totaling 83,300,474 shares[11]. - The company has 31,225,514 shares with no restrictions on sale held by the largest shareholder[11]. - The total number of preferred shareholders is not applicable[13]. - The company is currently unknown if there are any related party relationships among the top shareholders[12]. Expenses and Investments - Research and development expenses increased by 32.65% to ¥22,181,208.87, primarily due to increased outsourcing costs[9]. - The company reported a significant increase of 240.09% in construction in progress, amounting to ¥16,967,802.88, attributed to the establishment of an emergency material reserve[9]. - The company’s prepayments increased by 47.65% to ¥44,045,149.55, due to changes in payment methods[9]. - Cash paid for purchasing goods and services increased to RMB 2,038,789,383.46 from RMB 1,788,933,930.54, reflecting a rise of 13.93%[26]. - Cash paid to employees rose to RMB 193,152,134.31 from RMB 165,469,006.77, indicating an increase of 16.74%[26]. Comprehensive Income - Other comprehensive income after tax was RMB 41,124,427.10, significantly higher than RMB 687,744.00 in the previous year[25]. - Total comprehensive income for the period was RMB 100,299,560.88, compared to RMB 73,701,992.13 in the same period last year[25].
浙江震元(000705) - 2021 Q3 - 季度财报